NeuroMetrix Launches www.SENSUSRx.com

This press release is an announcement submitted by NeuroMextrix, Inc., and was not written by Diabetes Health.

Dec 10, 2013

Waltham, Mass.-based NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, has announced the launch of a consumer website, www.SENSUSRx.com.

The website provides patients and physicians with a one-stop location for information about chronic pain such as painful diabetic neuropathy and the SENSUSTM Pain Management System.

The system is a wearable non-invasive electrical nerve stimulator that offers patients a fast-acting, non-narcotic option for relief from chronic pain. The lightweight device can be worn during the day when users are active, or at night while they are sleeping. It is specifically designed for people with diabetes who suffer from chronic pain from diabetic neuropathy, which affects up to 5 million people in the United States alone.

The website contains a variety of content including interactive tools to help people evaluate and discuss chronic pain with their physicians, video testimonials of SENSUS users, and product support materials such as an instructional video. The website also contains social media features including a blog that will point visitors to the latest relevant research and provide updates on SENSUS and related technologies.

"PDN is a large problem in the diabetes community," said Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix. "We believe that there is an important role for us to play in managing pain due to PDN, and that this website will be a useful tool to reach this audience. It contains a wide range of product and disease information that we intend to further expand over time."

About NeuroMetrix

NeuroMetrix's development and marketing focus is on home use and point-of-care devices for the treatment and management of chronic pain, peripheral neuropathies, and associated neurological disorders. The company is currently focused on diabetic neuropathies, which affect over 50percent of people with diabetes.

Besides SENSUS, the company also markets the DPNCheck® device, a point-of-care test for the detection of early-stage diabetic neuropathy.

Click Here To View Or Post Comments

Categories: Diabetic Neuropathy, DPNCheck, NeuroMetrix, SENSUS


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Dec 10, 2013

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.